Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
L-Leucine, N-((1,1-dimethylethoxy)carbonyl)- → 6-[(4-Fluoro-phenyl)-hydroxy-methyl]-pyridine-2-carboxylic acid [(S)-3-methyl-1-(5-methyl-[1,2,4]oxadiazol-3-yl)-butyl]-amide
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | L-Leucine, N-((1,1-dimethylethoxy)carbonyl)- | HCID 83170 | — |
| 반응물 | 6-((4-Fluorophenyl)(hydroxy)methyl)picolinic acid | HCID 71087341 | — |
| 반응물 | (S)-5-methyl-alpha-(2-methylpropyl)-1,2,4-oxadiazole-3-methanamine hydrochloride | HCID 71087826 | — |
| 생성물 | 6-[(4-Fluoro-phenyl)-hydroxy-methyl]-pyridine-2-carboxylic acid [(S)-3-methyl-1-(5-methyl-[1,2,4]oxadiazol-3-yl)-butyl]-amide | HCID 71105702 | — |
반응 단계
The title compound was synthesized in analogy to Example 1, using 6-((4-fluorophenyl)(hydroxy)methyl)picolinic acid and (S)-5-methyl-α-(2-methylpropyl)-1,2,4-oxadiazole-3-methanamine hydrochloride (which was prepared from (2S)-2-[(tert-butoxycarbonyl)amino]-4-methylpentanoic acid (CAN 13139-15-6) in analogy to the procedures described in Example 38 a to e) as starting materials. MS (EI): m/e=399.2 [M+H]+.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US09321727B2 |
| 출처 데이터셋 | uspto-grants-2016_04 |
| ORD ID | ord-e0c2caf64fa344c1bcbc2e0178d3496f |
| 출처 메모 | uspto-grants-2016_04 |